Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole vs Anastrozole in Adjuvant Breast Cancer
NCT00248170Phase 3Completed
- Sponsor
- Novartis
- Start
- Dec 2005
- Primary completion
- Sep 2014
- Modality
- Orthosteric Ligands
- Countries
- 20
01
Overview
A Phase 3 trial of letrozole in breast cancer, sponsored by Novartis. Started Dec 2005; status: completed.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00248170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00248170.